Leading AI computing printed circuit board (PCB) manufacturer Delton Technology has listed on the HKEX on 20 March, raising HKD3.31 billion (USD422 million) and completes the company’s dual listing in the Chinese mainland and Hong Kong, following its debut on the SZSE’s main board in 2024. Paul Hastings, AllBright Law Offices, Thailand’s Starry Law Firm, Sullivan & Cromwell and Jia Yuan Law Offices provided legal support.
Consultancy Frost & Sullivan said Delton Technology ranked first among computing server manufacturers headquartered in the Chinese mainland by cumulative revenue from 2022 to 2024, and third globally.
Delton issued 46 million shares priced at HKD71.88 each. On its debut, the stock opened at HKD95.05, representing a 32.2% increase above the issue price. CITIC Securities and HSBC acted as joint sponsors.
The IPO attracted 12 cornerstone investors, including CPE, HK Greenwoods and UBS Asset Management, which subscribed for nearly 45% of the total proceeds.
Paul Hastings acted as Delton Technology’s Hong Kong and US legal counsel, led by founding partner and chair of Greater China Raymond Li and partner Steven Hsu. AllBright Law Offices advised on PRC law, with senior partner Jiang Peng and partners Liu Qingli and Yang Rong participating. Starry Law Firm advised on Thailand laws.
Sullivan & Cromwell advised the underwriters on Hong Kong and US law, led by the Beijing office’s managing partner, Gwen Wong, the Hong Kong office’s managing partner Ng Kay Ian and partner Lin Ching-Yang. Jia Yuan Law Offices served as the underwriters’ PRC legal counsel, with partners Wei Pei and Du Qian leading the team and senior counsels Li Xudong and Li Xueying participating.
Headquartered in Guangdong, Delton Technology was established in 2002, focusing on the R&D, production and sale of customised PCB products for data centres, cloud computing, AI and 5G communications. Its main manufacturing bases are located in Guangzhou and Dongguan in Guangdong province, Huangshi in Hubei province and Prachinburi in Thailand.
The prospectus stated that the proceeds would be mainly used for expanding and upgrading the production facilities at its Guangzhou base, constructing the second phase of its Thailand base, enhancing R&D capabilities, and supporting working capital and general corporate purposes.
